Speaker Profile

___	__
	Biography Dr. Flood is currently a professor in the department of Obstetrics and Gynaecology at the University of Alberta in the division of Urogynaecology. She has held multiple roles in education, most recently as the coordinator of the medical school reproductive block. Her interest in transgender care began with the initiation of a multidisciplinary clinic providing post-operative care for gender diverse patients that had undergone bottom surgery in Montreal. She is privileged to work with an incredible group of physicians and allied health in the Lois Hole Urogynecology clinic. Disclosure I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Direct financial payments including receipt of honoraria: Lupin Pharma - Membership on advisory boards or speakers’ bureaus: Lupin Pharma I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication). I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Flood is currently a professor in the department of Obstetrics and Gynaecology at the University of Alberta in the division of Urogynaecology. She has held multiple roles in education, most recently as the coordinator of the medical school reproductive block. Her interest in transgender care began with the initiation of a multidisciplinary clinic providing post-operative care for gender diverse patients that had undergone bottom surgery in Montreal. She is privileged to work with an incredible group of physicians and allied health in the Lois Hole Urogynecology clinic.
Disclosure
I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Direct financial payments including receipt of honoraria: Lupin Pharma - Membership on advisory boards or speakers’ bureaus: Lupin Pharma I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication). I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).